DrugPatentWatch Database Preview
Patent: 8,540,967
» See Plans and Pricing
Summary for Patent: 8,540,967
| Title: | Porphyrazine optical and dual optical/MR contrast and therapeutic agents |
| Abstract: | Porphyrazines capable of localizing in a tumor of a mammal are disclosed. The porphyrazines are used in methods of imaging a tumor and in methods of treating tumors, either alone or in combination with a chemotherapeutic agent and/or radiation. |
| Inventor(s): | Barrett; Anthony G. M. (London, GB), Trivedi; Evan R. (Evanston, IL), Hoffman; Brian M. (Evanston, IL) |
| Assignee: | Hoffman/Barrett, L.L.C. (Evanston, IL) |
| Application Number: | 13/062,031 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,540,967
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 002 | 2004-02-26 | Start Trial | Hoffman/Barrett, L.L.C. (Evanston, IL) | 2028-09-08 | RX | search | |
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | Start Trial | Hoffman/Barrett, L.L.C. (Evanston, IL) | 2028-09-08 | RX | search | |
| Sigma Tau | ONCASPAR | pegaspargase | VIAL | 103411 | 001 | 1994-02-01 | Start Trial | Hoffman/Barrett, L.L.C. (Evanston, IL) | 2028-09-08 | RX | search | |
| Chiron | PROLEUKIN | aldesleukin | VIAL | 103293 | 001 | 1992-05-05 | Start Trial | Hoffman/Barrett, L.L.C. (Evanston, IL) | 2028-09-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,540,967
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010028216 | Start Trial |
| United States of America | 2011293531 | Start Trial |
| Japan | 2012502052 | Start Trial |
| Japan | 5792066 | Start Trial |
| European Patent Office | 2340041 | Start Trial |
| European Patent Office | 2599497 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
